Giuseppe
Emeritus
Extracorporeal Membrane Oxygenation for Pandemic (H1N1) 2009 (Emerg Infect Dis., extract, edited)
[Source Full PDF Document: LINK. EDITED.]
DOI: 10.3201/eid1512.091434
Suggested citation for this article: Firstenberg MS, Blais D, Louis LB, Stevenson KB, Sun B, Mangino JE. Extracorporeal membrane oxygenation for pandemic (H1N1) 2009 [letter]. Emerg Infect Dis. 2009 Dec; [Epub ahead of print]
Extracorporeal Membrane Oxygenation for Pandemic (H1N1) 2009
To the Editor:
As the world struggles with the challenges of influenza A pandemic (H1N1) 2009, it is clear that treatment options for critically ill infected patients are suboptimal because deaths continue to be reported in otherwise young and healthy patients.
Extracorporeal membrane oxygenation (ECMO) is an established therapeutic option for patients with medically refractory cardiogenic or respiratory failure.
We describe the successful use of ECMO in a patient with complicated pneumonia and influenza A pandemic (H1N1) 2009 virus infection.
Our patient, a 21-year-old woman who was 4 months postpartum, had poorly controlled insulin-dependent diabetes (hemoglobin A1C level 13.2 mg/dL).
She sought treatment at another hospital after 3 days of respiratory symptoms, a productive cough after working in her garden, and a fever >103?F.
Her condition rapidly deteriorated, and she required mechanical ventilation, vasoactive medications, and drotecogin-α (Xigris; Eli Lilly and Company, Indianapolis, IN, USA) for profound shock.
(...)
-
-----
[Source Full PDF Document: LINK. EDITED.]
DOI: 10.3201/eid1512.091434
Suggested citation for this article: Firstenberg MS, Blais D, Louis LB, Stevenson KB, Sun B, Mangino JE. Extracorporeal membrane oxygenation for pandemic (H1N1) 2009 [letter]. Emerg Infect Dis. 2009 Dec; [Epub ahead of print]
Extracorporeal Membrane Oxygenation for Pandemic (H1N1) 2009
To the Editor:
As the world struggles with the challenges of influenza A pandemic (H1N1) 2009, it is clear that treatment options for critically ill infected patients are suboptimal because deaths continue to be reported in otherwise young and healthy patients.
Extracorporeal membrane oxygenation (ECMO) is an established therapeutic option for patients with medically refractory cardiogenic or respiratory failure.
We describe the successful use of ECMO in a patient with complicated pneumonia and influenza A pandemic (H1N1) 2009 virus infection.
Our patient, a 21-year-old woman who was 4 months postpartum, had poorly controlled insulin-dependent diabetes (hemoglobin A1C level 13.2 mg/dL).
She sought treatment at another hospital after 3 days of respiratory symptoms, a productive cough after working in her garden, and a fever >103?F.
Her condition rapidly deteriorated, and she required mechanical ventilation, vasoactive medications, and drotecogin-α (Xigris; Eli Lilly and Company, Indianapolis, IN, USA) for profound shock.
(...)
-
-----